Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC)

Texto completo
Autor(es):
Storti, Camila Baldin [1, 2] ; de Oliveira, Rogerio Antonio [3] ; de Carvalho, Marcio [4] ; Hasimoto, Erica Nishida [5] ; Cataneo, Daniele Cristina [5] ; Maria Cataneo, Antonio Jose [5] ; De Faveri, Julio [6] ; Vasconcelos, Elton Jose R. [7] ; dos Reis, Patricia Pintor [5, 8] ; Nogueira Cano, Maria Isabel [1]
Número total de Autores: 10
Afiliação do(s) autor(es):
[1] Sao Paulo State Univ UNESP, Biosci Inst, Genet Dept, Botucatu, SP - Brazil
[2] Univ Sao Paulo, Fac Med, Genet Dept, Ribeirao Preto, SP - Brazil
[3] Sao Paulo State Univ UNESP, Biostat Dept, Biosci Inst, Botucatu, SP - Brazil
[4] Sao Paulo State Univ UNESP, Fac Vet Med & Anim Sci, Fac Med, Botucatu, SP - Brazil
[5] Sao Paulo State Univ UNESP, Fac Med, Dept Surg & Orthoped, Botucatu, SP - Brazil
[6] Sao Paulo State Univ UNESP, Fac Med, Dept Pathol, Botucatu, SP - Brazil
[7] Univ Leeds, Leeds Omics, Leeds, W Yorkshire - England
[8] Sao Paulo State Univ UNESP, Fac Med, Expt Res Unity UNIPEX, Botucatu, SP - Brazil
Número total de Afiliações: 8
Tipo de documento: Artigo Científico
Fonte: Experimental and Molecular Pathology; v. 112, FEB 2020.
Citações Web of Science: 0
Resumo

In the past decade, research efforts were made to identify molecular biomarkers useful as therapeutic targets in Non-Small Cell Lung Cancer (NSCLC), the most frequent type of lung carcinoma. NSCLC presents different histological subtypes being the most prevalent LUSC (Lung Squamous Cell Cancer) and LUAD (Lung Adenocarcinoma), and only a subset of LUAD patients' present tumors expressing known targetable genetic alterations. Telomeres and its components, including telomerase, the enzyme that replenishes telomeres, have been considered potential cancer biomarkers due to their crucial role in cell proliferation and genome stability. Our study aims to quantify expression changes affecting telomere-associated genes and ncRNAs associated with telomere regulation and maintenance in NSCLC. We first assessed the transcriptome (RNA-Seq) data of NSCLC patients from The Cancer Genome Atlas (TCGA) and then we tested the expression of telomere-associated genes and telomeric ncRNAs (TERC, telomerase RNA component, and TERRA, telomere repeat-containing RNA) in Brazilian NCSLC patient samples by quantitative RT-PCR, using matched normal adjacent tissue samples as the control. We also estimated the mean size of terminal restriction fragments (TRF) of some Brazilian NSCLC patients using telomeric Southern blot. The TCGA analysis identified alterations in the expression profile of TERT and telomere damage repair genes, mainly in the LUSC subtype. The study of Brazilian NSCLC samples by RT-qPCR showed that LUSC and LUAD express high amounts of TERT and that although the mean TRF size of tumor samples was shorter compared to normal cells, telomeres in NSCLC are probably maintained by telomerase. Also, the expression analysis of Brazilian NSCLC samples identified statistically significant alterations in the expression of genes involved with telomere damage repair, as well as in TERC and TERRA, mainly in the LUSC subtype. We, therefore, concluded that telomere maintenance genes are significantly deregulated in NSCLC, representing potential biomarkers in the LUSC subtype. (AU)

Processo FAPESP: 16/06936-6 - Genes e proteínas associados aos telômeros como biomarcadores em carcinoma pulmonar de células não pequenas (NSCLC)
Beneficiário:Camila Baldin Storti
Linha de fomento: Bolsas no Brasil - Mestrado
Processo FAPESP: 12/50161-8 - Estudo da estrutura e função da chaperona Hsp90 com ênfase no seu papel em homeostase celular
Beneficiário:Carlos Henrique Inacio Ramos
Linha de fomento: Auxílio à Pesquisa - Temático
Processo FAPESP: 11/13213-7 - Biomarcadores prognósticos em carcinoma de pulmão não-pequenas células: identificação de alvos terapêuticos potenciais
Beneficiário:Patricia Pintor dos Reis
Linha de fomento: Auxílio à Pesquisa - Regular